Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis

Advances in Therapy

Volumn 26, Issue 9, 2009, Pages 858-871

  Gruenwald, Joerg ^a   Petzold, Ellen ^b   Busch, Regina ^a   Petzold, Heinz Peter ^b   Graubaum, Hans Joachim ^a  

^a Analyze and Realize GmbH   (Germany)

^b Rüdnitzer Chaussee 10   (Germany)

Author keywords

Comparison study; Docosahexaenoic acid; Double blind; Eicosapentaenoic acid; Glucosamine sulfate; Omega 3 fatty acids; Osteoarthritis; Randomized; WOMAC

Indexed keywords

GLUCOSAMINE SULFATE; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ERYTHEMA; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MORNING STIFFNESS; MULTICENTER STUDY; PAIN ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; VISUAL ANALOG SCALE;

ADULT; AGED; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FEMALE; GLUCOSAMINE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE;

EID: 76749144726     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0060-3     Document Type: Article

References (39)

1. A.D. Woolf B. Pfleger 2003 Burden of major musculoskeletal conditions Bull World Health Organ 81 646 656 14710506
2. C.L. Baker Jr C.M. Ferguson 2005 Future treatment of osteoarthritis Orthopedics 28suppl.2 227 234
3. P. Sarzi-Puttini M.A. Cimmino R. Scarpa 2005 Osteoarthritis: an overview of the disease and its treatment strategies Semin Arthritis Rheum 35 suppl.1 1 10 10.1016/j.semarthrit.2005.01.013 1:CAS:528:DC%2BD2MXntVOisL4%3D 16084227 (Pubitemid 41097249)
4. L.G. Ameye W.S. Chee 2006 Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence Arthritis Res Ther 8 R127 10.1186/ar2016 16859534
5. F. Berenbaum 2008 New horizons and perspectives in the treatment of osteoarthritis Arthritis Res Ther 10 suppl.2 S1 10.1186/ar2462 19007426
6. A. Mobasheri S.J. Vannucci C.A. Bondy 2002 Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis Histol Histopathol 17 1239 1267 1:CAS:528:DC%2BD38XptFWmtL4%3D 12371151
7. T. Aigner H.A. Kim 2002 Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration Arthritis Rheum 46 1986 1996 10.1002/art.10554 1:CAS:528:DC%2BD38XmvFOqtL4%3D 12209500 (Pubitemid 34894752)
8. Towheed TE, Maxwell L, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2008;CD002946.
9. J.J. Kim H.E. Conrad 1974 Effect of D-glucosamine concentration on the kinetics of mucopolysaccharide biosynthesis in cultured chick embryo vertebral cartilage J Biol Chem 249 p3091 3097
10. S. Owens P. Wagner C.T. Vangsness Jr. 2004 Recent advances in glucosamine and chondroitin supplementation J Knee Surg 17 185 193 15553585
11. K. Pavelka J. Gatterova M. Olejarova S. Machacek G. Giacovelli L.C. Rovati 2002 Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, doubleblind study Arch Intern Med 162 2113 2123 10.1001/archinte.162.18.2113 1:CAS:528: DC%2BD38XosFSms7Y%3D 12374520 (Pubitemid 35168220)
12. J.Y. Reginster R. Deroisy L.C. Rovati 2001 Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 357 251 256 10.1016/S0140-6736(00) 03610-2 1:CAS:528:DC%2BD3MXptVyqsw%3D%3D 11214126 (Pubitemid 32120855)
13. K. Förster A. Reichelt 1998 Gonarthrose - Aktuelle Aspekte in der Therapie mit Glucosaminsulfat (dona 200-S) Fortsch Med 116 suppl.183 1 12
14. A.J. Matheson C.M. Perry 2003 Glucosamine: a review of its use in the management of osteoarthritis Drugs Aging 20 1041 1060 10.2165/00002512- 200320140-00004 1:CAS:528:DC%2BD2cXitFCktw%3D%3D 14651444 (Pubitemid 37549879)
15. Müller-Fabender H, Bach G. D-Glucosamine-sulfate als nebenwirkungsarme alternative zu nichtsteroidalen antirheumatika. In: Bach G, Stock K, editors. Aktuelle Rheumatologie Bayreuth-Pathologie-Labor-Untersuchung- Therapie 1989. Köln: Echo Verlags-GmbH; 1990;109-124.
16. W. Noack M. Fischer K.K. Forster L.C. Rovati I. Setnikar 1994 Glucosamine sulfate in osteoarthritis of the knee Osteoarthritis Cartilage 2 51 59 10.1016/S1063-4584(05)80006-8 1:STN:280:DC%2BD3MvpvFKlsg%3D%3D 11548224 (Pubitemid 24159680)
17. A. Reichelt K.K. Forster M. Fischer L.C. Rovati I. Setnikar 1994 Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study Arzneimittelforschung 44 75 80 1:STN:280:DyaK2c7otlehuw%3D%3D 8135881
18. N. Poolsup C. Suthisisang P. Channark W. Kittikulsuth 2005 Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials Ann Pharmacother 39 1080 1087 10.1345/aph.1E576 1:CAS:528:DC%2BD2MXltlOns70%3D 15855241 (Pubitemid 40695976)
19. J.W. Anderson R.J. Nicolosi J.F. Borzelleca 2005 Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy Food Chem Toxicol 43 187 201 10.1016/j.fct.2004.11. 006 1:CAS:528:DC%2BD2MXhtVGkug%3D%3D 15621331 (Pubitemid 40044716)
20. D.O. Clegg D.J. Reda C.L. Harris 2006 Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis N Engl J Med 354 795 808 10.1056/NEJMoa052771 1:CAS:528:DC%2BD28XhslyqsrY%3D 16495392 (Pubitemid 43290918)
21. T.A. Sanders 1993 Marine oils: metabolic effects and role in human nutrition Proc Nutr Soc 52 457 472 10.1079/PNS19930086 1:CAS:528: DyaK2cXltlCluw%3D%3D 8302887
22. P.C. Calder 2006 n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases Am J Clin Nutr 83 suppl.6 1505 1519
23. C.N. Serhan M. Arita S. Hong K. Gotlinger 2004 Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers Lipids 39 1125 1132 10.1007/s11745-004-1339-7 1:CAS:528:DC%2BD2MXotlWksg%3D%3D 15726828 (Pubitemid 40129055)
24. Y.Z. Fang S. Yang G. Wu 2002 Free radicals, antioxidants, and nutrition Nutrition 18 872 879 10.1016/S0899-9007(02)00916-4 1:CAS:528: DC%2BD38XnsVahtLc%3D 12361782 (Pubitemid 35292261)
25. K.L. Rennie J. Hughes R. Lang S.A. Jebb 2003 Nutritional management of rheumatoid arthritis: a review of the evidence J Hum Nutr Diet 16 97 109 10.1046/j.1365-277X.2003.00423.x 1:STN:280:DC%2BD3s7kslKhsQ%3D%3D 12662368 (Pubitemid 36527084)
26. J.M. Kremer W. Jubiz A. Michalek 1987 Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study Ann Intern Med 106 497 503 1:STN:280:DyaL2s7lsVyisA%3D%3D 3030173
27. H. van der Tempel J.E. Tulleken P.C. Limburg F.A. Muskiet M.H. van Rijswijk 1990 Effects of fish oil supplementation in rheumatoid arthritis Ann Rheum Dis 49 76 80 10.1136/ard.49.2.76 2138449
28. B. Galarraga M. Ho H.M. Youssef 2008 Cod liver oil (n-3 fatty acids) as a non-steroidal antiinflammatory drug sparing agent in rheumatoid arthritis Rheumatology (Oxford) 47 665 669 10.1093/rheumatology/ken024 1:CAS:528:DC%2BD1cXkvFymtrc%3D (Pubitemid 351619210)
29. K.D. Hankenson B.A. Watkins I.A. Schoenlein K.G. Allen J.J. Turek 2000 Omega-3 fatty acids enhance ligament fibroblast collagen formation in association with changes in interleukin-6 production Proc Soc Exp Biol Med 223 88 95 10.1046/j.1525-1373.2000.22312.x 1:CAS:528:DC%2BD3cXksVKqur8%3D 10632966
30. European Agency for the Evaluation of Medicinal Products: Human Medicines Evaluation Unit 1998 Points to consider on clinical investigation of medicinal products used in the treatment of osteoarthritis CPMP/EWP/784/97 1 7
31. J.C. Maroon J.W. Bost 2006 Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain Surg Neurol 65 326 331 10.1016/j.surneu.2005.10.023 16531187 (Pubitemid 43384072)
32. G. Stucki D. Meier S. [. Stucki 1996 Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index Z Rheumatol 55 40 49 1:STN:280:DyaK2s%2FitFOruw%3D%3D 8868149
33. C.H. MacLean W.A. Mojica S.C. Morton 2004 Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis Evid Rep Technol Assess (Summ) 89 1 4
34. Y. Wang A.E. Wluka A.M. Hodge 2008 Effect of fatty acids on bone marrow lesions and knee cartilage in healthy, middle-aged subjects without clinical knee osteoarthritis Osteoarthritis Cartilage 16 579 583 10.1016/j.joca.2007.09. 007 1:STN:280:DC%2BD1c3mvF2ltQ%3D%3D 17937997
35. T.E. McAlindon M.P. LaValley J.P. Gulin D.T. Felson 2000 Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis JAMA 283 1469 1475 10.1001/jama.283.11.1469 1:CAS:528: DC%2BD3cXit1Sms7c%3D 10732937
36. S.C. Vlad M.P. LaValley T.E. McAlindon D.T. Felson 2007 Glucosamine for pain in osteoarthritis: why do trial results differ Arthritis Rheum 56 2267 2277 10.1002/art.22728 1:CAS:528:DC%2BD2sXovFSgtL0%3D 17599746 (Pubitemid 47173575)
37. J.Y. Reginster 2007 The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest Arthritis Rheum 56 2105 2110 10.1002/art.22852 1:CAS:528:DC%2BD2sXovFSgsLk%3D 17599727 (Pubitemid 47173556)
38. O. Bruyere J.Y. Reginster 2007 Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis Drugs Aging 24 573 580 10.2165/00002512-200724070-00005 1:CAS:528:DC%2BD2sXhtVeqtLnP 17658908 (Pubitemid 47195676)
39. G. Herrero-Beaumont J.A. Ivorra M. Del Carmen Trabado 2007 Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator Arthritis Rheum 56 555 567 10.1002/art.22371 1:CAS:528:DC%2BD2sXislShur8%3D 17265490 (Pubitemid 46271981)